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The nervous system is complex not simply because of the enormous number of neurons
it contains but by virtue of the specificity with which they are connected. Unraveling
this specificity is the task of neuroanatomy. In this endeavor, neuroanatomists have
traditionally exploited an impressive array of tools ranging from the Golgi method
to electron microscopy. An ideal method for studying anatomy would label neurons
that are interconnected, and, in addition, allow expression of foreign genes in these
neurons. Fortuitously, nature has already partially developed such a method in the form
of neurotropic viruses, which have evolved to deliver their genetic material between
synaptically connected neurons while largely eluding glia and the immune system. While
these characteristics make some of these viruses a threat to human health, simple
modifications allow them to be used in controlled experimental settings, thus enabling
neuroanatomists to trace multi-synaptic connections within and across brain regions.
Wild-type neurotropic viruses, such as rabies and alpha-herpes virus, have already
contributed greatly to our understanding of brain connectivity, and modern molecular
techniques have enabled the construction of recombinant forms of these and other
viruses. These newly engineered reagents are particularly useful, as they can target
genetically defined populations of neurons, spread only one synapse to either inputs or
outputs, and carry instructions by which the targeted neurons can be made to express
exogenous proteins, such as calcium sensors or light-sensitive ion channels, that can
be used to study neuronal function. In this review, we address these uniquely powerful
features of the viruses already in the neuroanatomist’s toolbox, as well as the aspects of
their biology that currently limit their utility. Based on the latter, we consider strategies for
improving viral tracing methods by reducing toxicity, improving control of transsynaptic
spread, and extending the range of species that can be studied.
Keywords: neurotropic virus, neuroanatomy, review, transsynaptic tracing, expression vectors
Introduction
The Brain: a Problem of “Organized Complexity”
In 1958, Warren Weaver (Weaver, 1958), a mathematician and former Director for the Natural
Sciences of The Rockefeller Foundation, introduced an important distinction between what he
called ‘‘problems of disorganized complexity’’ and those of ‘‘organized complexity.’’ The former
consist of situations in which a very large number of individual entities might be involved, such
as the individual molecules within a container of nitrogen gas, but where the interactions between
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the entities were helter-skelter; that is, there was no special
relationship between any one molecule and any other. The
aggregate behavior of such systems could be remarkably well
described using statistical methods, one important example
being the development of statistical mechanics in the late 19th
century by Gibbs, Boltzmann and others. The second class of
problems—those of organized complexity—were different in the
key respect that the particular ways in which the individuals
interacted was a critical part of the problem. This may consist
of individual humans participating in a market economy, of
honeybees within a hive, or of neurons within a brain.
In this last case, it is the connections that define the
emergent behavior of the system. Knowing these is arguably
as or more important than knowing the precise location of
the individual neurons—a possibility that was imaginatively
explored in Arnold Zuboff’s ‘‘The Story of a Brain,’’ (Zuboff,
1981) in which his mad-scientist characters create a ‘‘spread-
brain’’ where the brain’s individual hemispheres (and, ultimately,
individual neurons) could be kept alive in separate nutrient
baths, preserving the brain’s owner’s consciousness so long as
they were appropriately wired together. Practical (and ethical)
issues aside, this idea that if one understood all of the brain’s
connections—the so-called ‘‘connectome’’—one would be a long
way towards understanding how it works, continues to drive
modern neuroanatomy.
A Brief, Focused History of Connection Mapping
with Non-viral Tracers
In this section, we briefly describe the historical development
of non-viral tracers, mainly as it pertains to issues relevant to
the viral tracers we discuss below. For readers desiring a more
thorough and technical treatment of this topic, we have provided
relevant references in Table 1 and further recommend several
excellent reviews: for early, transport-based methods, see Cowan
and Cuenod (1975) and for more recent methods Lanciego and
Wouterlood (2011) and Wouterlood et al. (2014).
With Augustus Waller’s (1850) histological description of
degenerating axons following section of the glossopharyngeal
and hypoglossal nerves of frogs, it became possible to use
‘‘Wallerian degeneration’’ to trace the course of nerve fibers
within the brain. This lesion-based method was greatly
augmented by the discovery that the degenerating nerve
terminals could be labeled with metallic silver (Hoff, 1932;
Glees, 1946; Nauta and Gygax, 1951; Fink and Heimer, 1967).
In a separate development, the silver-based Golgi method,
most famously exploited by Ramón y Cajal (1909), allowed
one to visualize entire neurons, including their dendrites and
unmyelinated axons, thus permitting a scientist with a superb
visual imagination, such as Cajal possessed, to map out the first
‘‘circuits’’ with surprising perspicuity. While the Golgi method
produced beautifully labeled neurons whose morphology could
thus be studied in detail, it did not permit the reliable
demonstration of long-distance anatomical connections; this
required the discovery of molecules that would be taken up and
actively transported by neurons.
The very fact of Wallerian degeneration made it clear
that the distal part of the axon was somehow dependent for
its viability on substances supplied by the cell body, and,
consequently, that there must exist mechanisms to transport
these substances. This deduction was experimentally confirmed
by Paul Weiss and colleagues at the University of Chicago (Weiss
and Hiscoe, 1948) and not long thereafter exploited to trace
connections with the use of radioactively tagged amino acids
that were taken up by cell bodies, incorporated into proteins
and transported anterogradely to axon terminals where they
could be rendered visible with autoradiography (Taylor and
Weiss, 1965; Lasek et al., 1968). This method, while subject to
many limitations (see Cowan and Cuenod, 1975 for details),
represented a revolution in neuroanatomy, as it was the first time
that connections could be directly demonstrated without having
to first inflict damage on the structures of interest. This opened
the door to experiments combining connectivity mapping with
measurements of neuronal function and development.
The first method that exploited the retrograde transport of
substances by axons was that demonstrated by the intramuscular
injection of proteins, such as, initially, fluorescently labeled
albumin (Kristensson, 1970), and then, with greater success,
horseradish peroxidase (HRP; Kristensson and Olsson, 1971)
which labeled the appropriate pool of motor neurons. HRP
was subsequently shown to work in the central nervous system
as well (LaVail and LaVail, 1972). It is interesting to note
that the early pioneers of these methods were well aware of
the powerful cell biological phenomena into which they had
tapped. The final sentence of the paper by Kristensson and
Olsson (1971) is particularly prescient: ‘‘The finding that axons
are capable of taking up exogenous proteins and transporting
them in a retrograde direction to the nerve cell body may have
important implications for the understanding of certain puzzling
neurobiological phenomena such as trophic influences of end-
organs on the nerve cell body, the signal for chromatolysis
after axonal lesions, and how certain toxins and neurovirulent
viruses spread from the periphery to the central nervous
system.’’
The use of HRP provided an important benefit over
albumin, because its enzymatic activity could be exploited
to produce a visible reaction product when post-mortem
sections were incubated in a mixture of hydrogen peroxide and
diaminobenzidine (Graham and Karnovsky, 1965), a feature
that was further improved upon by the use of other substrates,
most notably tetramethyl benzidine (Mesulam, 1982). The
latter method could produce a reaction product consisting
of birefringent crystals that, when viewed under darkfield
illumination, revealed brightly labeled neuronal cell bodies on a
black background. Even so, these methods did not completely fill
neurons and their dendritic arbors, so while retrogradely labeled
cell bodies could be identified, their morphology remained
poorly defined (though, see Keefer et al., 1976). It was only
later, with the discovery of tracers such as biocytin (King
et al., 1989), Phaseolus vulgaris-leucoagglutinin (PHA-L; Gerfen
and Sawchenko, 1984) and biotinylated dextran amine (BDA;
Veenman et al., 1992), that ‘‘Golgi-like’’ fills of projection
neurons became possible.
While HRP continued to be a workhorse for neuroanatomists,
it lacked the desired degree of sensitivity, because its uptake
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TABLE 1 | Overview of non-viral neuroanatomical tracers.
Family Examples Dir Spd Fill? Reference
Small proteins Horseradish peroxidase (HRP)
albumin
R/A F N Kristensson and Olsson (1971)
LaVail and LaVail (1972)
Inorganic fluorescent
molecules Fast Blue (FB)
Diamidino yellow (DY)
Fluoro-gold (FG)
R M N Kuypers et al. (1979)
Bentivoglio et al. (1980)
Schmued and Fallon (1986)
Dextrans Fluoro-Ruby (FR) A/R M N Glover et al. (1986)
Biotinylated dextran amine (BDA) A/R Y Nance and Burns (1990)
Veenman et al. (1992)
Lectins Wheat germ agglutinin (WGA; WGA-HRP) R/A F N Schwab et al. (1978)
Phaseolus Gonatas et al. (1979)
vulgaris-leucoagglutinin (PHA-L) A Y Gerfen and Sawchenko (1984)
Beads Latex microspheres R F N Katz et al. (1984)
Katz and Iarovici (1990)
Bacterial toxins Tetanus R F N Stoeckel et al. (1977)
cholera (B fragment) R/A Schwab and Agid (1979)
Trojanowski et al. (1981)
Trophins Nerve growth factor (NGF) brain-derived
neurotrophic factor (BDNF)
R F N Hendry et al. (1974)
Stoeckel and Thoenen (1975)
Amino acids 3H-leucine A F/S N Cowan et al. (1972)
3H-proline Y Hendrickson (1982)
biocytin King et al. (1989)
Carbocyanine dyes DiI
DiO
A/R S N Honig and Hume (1986)
Honig and Hume (1989)
Abbreviations: “Dir”, direction; “A”, anterograde; “R”, retrograde (for bi-directionally transported substances, bold-face indicates predominant direction or most common
usage); “Spd”, speed; “F”, fast; “S”, slow; “M”, moderate; “Fill?”, Does the tracer produce Golgi-like fills of neuronal cell bodies?; “Y”, yes; “N”, no.
by neurons at the injection site was relatively inefficient. This
was improved dramatically by conjugating HRP to certain
plant lectins, especially wheat germ agglutinin (WGA; Gonatas
et al., 1979), a breakthrough that took tracing connections
from something of a dark art to a reliable technique that
even physiologists could use (M. S. Livingstone, personal
communication). Motivated by the notion that the improved
sensitivity was due to interactions of the lectins with specific
cell-surface molecules on neurons, investigators also explored
other conjugates, including cholera toxin (Trojanowski et al.,
1981, 1982) and tetanus toxin (Stoeckel et al., 1975; Schwab
and Agid, 1979), which were known to be retrogradely
transported by neurons and which were subsequently
shown to selectively interact with specific gangliosides that
were enriched on the surfaces of neurons (Stoeckel et al.,
1977).
While this brief history omits a number of important tracers,
such as the inorganic fluorescent dyes discovered by Kuypers
and colleagues (Kuypers et al., 1979; Bentivoglio et al., 1980),
we can already begin to see many of the key properties that
would make for an ideal tracer. First, it would be selectively and
efficiently taken up by neurons, preferably by intact cell bodies or
axon terminals and not damaged fibers (i.e., ‘‘axons of passage’’);
second, it could be targeted to a specific class of intracellular
motor proteins that would selectively transport it in either the
anterograde or the retrograde direction (Dodding and Way,
2011; Maday et al., 2014); third, upon arriving at its destination,
it could be readily amplified and rendered visible, providing
a Golgi-like fill with minimal need for histological processing;
and fourth, it would be available in a variety of different,
distinguishable colors so that experiments with multiple tracers
could be performed. A fifth property, not directly addressed
above, but a property of some classical tracers, e.g., (Schwab
et al., 1979), is that it could potentially cross synapses to
label second- and, possibly, higher-order neurons in a given
pathway.
Tracers exhibiting some of these properties have been
discovered over the past several decades by a combination
of trial-and-error, educated guesses and luck. However, given
the vast time and superior tinkering skills available to
Mother Nature, one is not surprised to learn that she has
already produced devices with all of these properties, in
the form of neurotropic viruses. What’s more, because they
carry information encoded by nucleic acids, they can be
genetically engineered for specific desired properties (e.g., to
travel in anterograde vs. retrograde directions; or to cross
or not cross synapses—see ‘‘Engineering Viruses to Control
Transport’’ Section) and also be used to introduce foreign
genes that can be used to easily detect their presence [e.g.,
green fluorescent protein, (GFP)] or, more powerfully, to
directly monitor or manipulate neuronal function (see ‘‘Viruses
Engineered to Carry Functional Genes’’ Section). After a
primer on viruses, we will describe some of the modern
neuroanatomical strategies permitted by viruses and their
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genetically altered cousins, ending with a discussion of possible
directions for further development of these powerful biological
tools.
A Primer on Viruses for Neuroanatomists
Each gene transfer application calls for a particular set of features
in a vector, which is defined here as a derivative of a virus used
for the delivery of genes. They include: target cell type(s), vector
genome size, expression level and duration, vector concentration
(titer), DNA or RNA genome, speed of expression after infection,
ease of altering the genome and capsid, and safety. One other
property of note is whether the virus has an envelope, a lipid
bilayer surrounding the capsid, derived from the host plasma
membrane. Enveloped viruses have glycoproteins inserted into
their envelope, and one can substitute the glycoprotein of one
virus for another, to create ‘‘pseudotypes,’’ which can alter
the host range of the virus (Hirst and Gotlieb, 1953). Viral
vectors commonly in use by neuroscientists, summarized in
Table 2, will be discussed in the next section, with a focus
on the features that underlie the choices of each vector for
application by neuroscientists. However, prior to the discussion
of specific properties, it is worth considering the overarching
replication potential of a vector, and how this relates to its use
by neuroanatomists.
To use a vector as a transsynaptic tracer, it must replicate,
that is, produce more infectious virion particles in the initially
infected (or ‘‘starter’’) cell, so that a connected cell can be
infected by transmission. A virus that can replicate is referred
to as ‘‘replication-competent,’’ and examples include the original
forms of pseudorabies virus (PRV; Card and Enquist, 2014)
and rabies virus (RABV; Kelly and Strick, 2000). Another type
of vector is crippled by deletion of an essential gene, but
replication can occur when the missing gene is supplied, in
trans. These ‘‘replication-conditional’’ vectors have an advantage
in that replication can be controlled through the delivery of
the missing component. Examples of replication-conditional
vectors are the Cre-dependent PRV (DeFalco et al., 2001) and
glycoprotein (G)-deleted RABV (Wickersham et al., 2007a). A
third category consists of vectors that are unable to replicate
at all, or ‘‘replication-incompetent’’ vectors. Some replication-
incompetent vectors are useful to neuroanatomists in that
they can be used as retrograde tracers; that is, they can be
taken up by axonal terminals, whereupon they travel to the
cell body and initiate vector gene expression [e.g., herpesvirus
(HSV) amplicon vectors, Spaete and Frenkel, 1982]. Replication-
incompetent vectors do not spread and thus are not transsynaptic
tracers. Some of them have been used for an additional role
for neuroanatomy, however, in that they can express genes
that aid in the transsynaptic tracing carried out by replication-
conditional vectors. For example, a viral G gene can be supplied
by a replication-incompetent adeno-associated vector (AAV) to
complement a replication-conditional RABV (G-deleted) virus.
For some viruses, such as HSV vectors, all of these types of
replication styles can be created by different types of genome
manipulation (Spaete and Frenkel, 1982; Ugolini et al., 1989;
Krisky et al., 1998; Lilley et al., 2001).
Viruses that do not Cross Synapses
Retroviridae
A retrovirus is an enveloped, single-stranded RNA virus. Its
most salient feature is that it provides for stable, long-term
gene expression by virtue of its ability to stably integrate
its DNA genome (created from its RNA genome upon entry
into a host cell) into a host cell’s genome, and express
virally-encoded genes from a wide range of integration sites
(Knipe and Howley, 2013). This ability to integrate distinguishes
it from other commonly used vectors, such as AAV. Target
cells that are dividing gradually lose viral genomes that are
not integrated, due to dilution, and thus any application
that requires retention of expression over a number of cell
cycles must use a virus that integrates. An example of such
an application for neuroscientists might be the introduction
of a retrovirus encoding a viral receptor, e.g., avian tumor
virus receptor A (TVA), into a progenitor zone early in
development. Integration would allow expansion of the number
of cells with the integrated TVA gene, so that there would
be a large number of TVA-expressing cells at some later
point, to facilitate targeted infection using tracing viruses
that contain the cognate glycoprotein, EnvA (as discussed in
‘‘Use of Monosynaptic and Transsynaptic Tracing in vivo’’
Section).
The two types of retroviruses commonly used as viral
vectors are the gamma-retroviruses and lentiviruses. The critical
distinction between these two types of retroviruses concerns
their ability to enter a host cell’s nucleus in order to integrate
the viral DNA. Viral gene expression requires that the genome
be integrated, so this step is essential to the use of these
viruses as vectors. Gamma-retroviruses are unable to gain
entry to the nucleus through an intact nuclear envelope, and
thus need a cell to undergo a nuclear envelope breakdown
during M phase in order to access a host cell’s genome. In
contrast, lentiviral DNA can enter the nucleus without nuclear
envelope breakdown, and thus can integrate in a postmitotic
cell. This feature makes lentiviruses particularly useful for gene
transfer into neurons (Naldini et al., 1996). Both types of
retroviruses have been modified to render them unable to
replicate after infection, i.e., they are replication-incompetent.
Lack of replication makes these vectors safe for use in the
laboratory (Schambach et al., 2013), and similarly does not lead
to disease in animals, with some rare exceptions due to alterations
in the host genome due to viral integration (Hacein-Bey-Abina
et al., 2003).
Genome size is an important consideration when choosing
a vector for a particular application. Lentiviruses and gamma-
retroviruses can package a genome of approximately 10 Kb
(Kumar et al., 2001), which allows for expression of more than
one gene, as well as use of more than one promoter or regulatory
element. In contrast, AAV can only package approximately
4.8 Kb. Retroviruses can express cDNAs from the viral long
terminal repeat (LTR) promoter, or they can be engineered to use
an internal, non-retroviral promoter, e.g., for tissue specificity
(Montiel-Equihua et al., 2012). In the latter case, use of a viral
genome rigged to lose the activity of the viral LTR appears to give
a greater probability of correct regulation of an internal promoter
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(Miyoshi et al., 1998; Ginn et al., 2003). However, even with
such crippled LTRs, internal promoters are not always properly
regulated, and the rules that govern regulation are not known.
Retroviral vectors can be engineered to express small-hairpin
RNAs (shRNAs) from Pol III promoters (Paddison et al., 2004;
Harpavat and Cepko, 2006), and can use multiple promoters in
TABLE 2 | Summary of viruses of interest to neuroanatomists.
Family Genome Size Titer* Comments/Applications Dir Cyto-toxic? Bio-safety
level
Retroviridae
Gamma-retrovirus,
e.g., Moloney Murine
Leukemia virus
(MMLV), lentivirus,
(e.g., HIV)
Positive-strand,
single strand RNA
that is made
into cDNA
9–12 Kb 107–
109 cfu/ml
Viral genome integrates into host
genome. Use gamma-retrovirus
when target cells are dividing
and want stable expression; use
lentivirus when target cells are
not dividing; expression level is
typically relatively low
– N BSL1–2
Parvoviridae
Adeno-associated
virus (AAV)
Single strand DNA 4.8 Kb 1012–
1013 gc/ml
Do not integrate; work well with
neurons for stable expression,
small genome can limit use of cell-
type-specific enhancer/promoter,
or large cDNAs; high titer allows
for co-infection with >1 genome
to enable combinations of genes
– N BSL1
Adenoviridae
Human adenovirus 5
(Ad5)
Double strand DNA 36 Kb 1010–
1012 vg/ml
Do not integrate; replication-
incompetent forms used for
rapid and transient expression
in neurons; capsids can elicit
inflammatory response. CAV is
used as a replication-incompetent
retrograde tracer
– N BSL2
Canine adenovirus (CAV) Double strand DNA 36 Kb 1010–
1012 vg/ml
As above for Ad5 – N BSL2
Herpesviridae
Alpha-herpesviruses,
HSV-1 and
Pseudorabies virus (PRV)
Double strand DNA 153 Kb
(HSV-1);
144 Kb
(PRV)
107– 109
cfu/ml
Large and complex genomes,
making for more difficult
genome engineering; replication-
competent and conditional
versions are used for
transsynaptic tracing
R/A Y BSL2
Two versions of replication-
incompetent forms, short-term
(ST) and long term (LT), are used
for gene transfer into neurons;
large genome capacity and rapid
onset of expression; can achieve
co-infection with >1 genome; can
go retrograde from injection site
R N BSL2
Rhabdoviridae
Rabies virus (RABV),
Vesicular stomatitis
virus (VSV)
Negative-strand,
single strand RNA
12 Kb 108–109 cfu/ml
(∆G)
1010– 1012
cfu/ml (wt)
Simple genome makes
engineering straightforward;
offer good strategy for selection
of gene expression level; genome
can NOT be recombined with
DNA recombinases (Cre and Flp)
R/A Y BSL1–2
Alphaviridae
Sindbis virus (SIN)
Semliki forest virus (SFV)
Positive-strand,
single strand RNA
12 Kb 108– 109
cfu/ml
Rapid expression makes it well
suited for delivery of transgenes
on a short time scale
– Y BSL2
Abbreviations: wt, wild type, i.e., replication-competent, meaning virus can spread, 1G, G gene is deleted rendering virus unable to spread unless the G gene is supplied
in trans, (i.e., by another genetic element such as AAV), Dir, direction of transsynaptic transmission; “A”, anterograde; “R”, retrograde (for bi-directional transsynaptic
transmission, bold-face indicates predominant direction or most common usage).*Titer: The concentration of virion particles and/or infectious units are measured differently
for different viruses. While the concentration of infectious units is the most useful for applications, such as cfu/ml (colony forming units/ml) or pfu/ml (plaque forming
units/ml), these are not always measured for technical reasons. Alternative methods typically assay viral genome concentration, and different descriptions are used in
different publications, e.g., gc/ml (genome copies/ml) or vg/ml (vector genomes/ml). This is important to note as the ratio of particles to infectious particles (p/pfu) can
be very high, from 10–10,000. The titers for a virus preparation vary widely due to effects of the genome alterations on virus replication and the preparation method; a
range is listed in the Table but there are stocks outside of this range. References: An overview of all of the viruses listed in Table 2 can be found in the following virology
textbooks: (Flint, 2009; Knipe and Howley, 2013).
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the same genome. For example, a lentivirus was designed to use
the Pol III promoters, H1 and U6, to express multiple shRNAs
targeting complexin-1 and complexin-2. The same virus used the
Pol II promoter, derived from the human ubiquitin-C gene, to
express an shRNA-resistant form of complexin-1 (Ahmad et al.,
2012).
The choice of the type of retrovirus to use is typically
driven by whether the target cell type is mitotic or postmitotic.
Gamma-retroviruses have been used to trace lineages in the
nervous system, as they will only integrate (and thus express)
in mitotic cells, which is exactly what one needs for lineage
tracing (Turner and Cepko, 1987). As mentioned previously,
lentiviruses are used when one wants to deliver genes to neurons.
Both types of retroviruses have been used for gene therapy in
humans, due to their stable integration, which provides for long-
term gene expression, and again, the choice of which type to
use takes into consideration whether the target cell is actively
dividing (Wiznerowicz and Trono, 2005; Hacein-Bey-Abina
et al., 2014).
Another issue to consider in choosing a viral vector is the
percentage of cells at an injection site that need to be infected
for the experimental outcome. A limitation of retroviruses is
that they do not grow to as high a titer (typically in the range
of 108–109 colony forming units per mL, cfu/mL) as AAVs
or adenovirus vectors, which can be several log10 units higher.
The expression level should also be taken into consideration.
In part, due to the fact that there is usually only a single
viral genome in an infected cell, the level of expression from
retroviruses tends to be modest (Wickersham et al., 2007a),
though a recently developed lentiviral vector with a tetracycline
regulatory element and activator may overcome this problem
for some applications (Cetin and Callaway, 2014). Relatively low
expression is a disadvantage of using these vectors, as not all
neuronal processes are well labeled.
The genome structure of retroviruses is fairly flexible,
allowing for the design of vectors using different types of
promoters and cargoes. In addition, retroviruses, which have
an RNA genome packaged in their capsids, create a DNA copy
of themselves after infection, which is integrated into the host
genome. This means that the integrated viral genome can be
modified by Cre- or Flp-mediated recombination (Gonçalves
et al., 2010; Sommer et al., 2010), and allows the use of
cellular promoters, neither of which is possible when using
RNA viruses. The virion particles also can be modified to suit
certain applications. Retrovirus particles have a lipid envelope,
and can accept the envelope glycoprotein from other viruses, or
pseudotyped with, for example, the avian EnvA glycoprotein that
targets the infection to cells that express the avian TVA receptor
(Bates et al., 1993; Holland et al., 1998). This approach has been
used to target infection for lineage studies (Beier et al., 2011a;
Hafler et al., 2012) as well as transsynaptic tracing studies using
RABV (Wickersham et al., 2007b) and vesicular stomatitis virus
(VSV; Beier et al., 2011b).
Parvoviridae—Adeno-Associated Virus (AAV)
AAV is a non-enveloped, single-stranded, small DNA virus of
the Parvovirus family (Knipe and Howley, 2013) that has proven
effective for gene transfer in the CNS (for a recent review of
AAV in the CNS, see Murlidharan et al., 2014). AAV can be used
for long-term, stable gene expression in neurons, with little or
no toxicity (Kaspar et al., 2002). Its other notable feature is that
it grows to very high titers, which can allow the simultaneous
infection of cells with more than one AAV vector. There are
hundreds of naturally occurring ‘‘species’’ of AAV (Gao et al.,
2004), referred to as serotypes, which can be exploited for
infection of different cell types. In addition to differences in
capsid proteins, the different serotypes have different sequences
in their inverted terminal repeats (ITRs), sequences required for
replication of the viral genome, as well as differences in the
viral replicases that recognize these sequences. The ITRs from
serotype 2 have been the most extensively employed in AAV
vectors. The ITR serotype is the number that is listed first in
the name of an AAV vector, while the capsid type is the second
number, e.g., AAV2/8 has the ITRs from AAV 2 and the capsid
proteins from AAV 8 (Gao et al., 2005). Serotypes vary in terms
of the speed of onset of viral gene expression, with some of the
serotypes being particularly slow, needing up to several weeks
for the maximum number of cells to show evidence of infection
(Vandenberghe et al., 2013). Some of the reasons for this remain
unknown, but uncoating and the need to replicate a second
strand of DNA (as the virus only packages a single DNA strand)
contribute to the lag time. AAV vectors with a genome that is self-
complementary, and thus are double-stranded in the capsid, are
much faster in terms of onset of expression as they do not need to
produce a second DNA strand before initiating gene expression
(McCarty et al., 2001; Gray et al., 2011). However, the packaging
size of these vectors is very small, about half that of conventional
vectors.
Another feature of a serotype to consider is the target
cell specificity (e.g., Burger et al., 2004; Cearley and Wolfe,
2006; Taymans et al., 2007; Zincarelli et al., 2008; Aschauer
et al., 2013), whether the capsid is transported away from the
inoculation site and, if transported, whether in the retrograde
(Taymans et al., 2007; Hollis et al., 2008; McFarland et al., 2009;
Towne et al., 2010; Masamizu et al., 2011; Aschauer et al.,
2013; Castle et al., 2014) or/and anterograde (Castle et al.,
2014) directions. AAVs can also access the CNS and PNS from
intravascular perfusion, with different efficacies and tropisms
depending upon the capsid (Zhang et al., 2011). Toxicity also
can vary with the serotype (Howard et al., 2008), or even
with a given virus preparation. Toxicity can be due to a
high level of expression of the encoded gene, and/or acute
inflammation, though this is typically quite low for AAV
(McPhee et al., 2006; Zhang et al., 2011; Sondhi et al., 2012),
especially relative to adenovirus (Seiler et al., 2007). T-cell
mediated toxicity for AAV-infected cells has been seen in
humans due to memory T cells (Mingozzi and High, 2013),
but has not been reported for rodents. In addition, there may
be toxic elements in a virus preparation that do not elicit
toxicity through immune system interactions. For example, we
have found that different preparations of the same genome
in the same capsid type can vary in toxicity, and others
have reported differences in toxicity among serotypes for cells
cultured from different areas of the CNS (Howard et al.,
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2008). Acute toxicity in certain preparations may be due to
the capsid itself, or to something that is tightly complexed
with the capsid, as we have been unable to eliminate toxicity
through multiple purification methods. However, dilution of
a stock has proven an effective approach to minimizing
toxicity.
In general, AAVs have proven to be very useful for long-
term, relatively high-level gene expression in the mammalian
CNS. In addition, as with retroviruses, their genome is double-
stranded DNA after they infect and convert their single stranded
packaged genome into a double strand. Their genomes can
thus be modified by recombinase technology, with the tightest
Cre-dependent vectors using two pairs of loxP sites, called Flip-
excision (FLEx) vectors (Schnütgen et al., 2003). Multiple Cre-
dependent vectors can be used to simultaneously infect the
same cells, but there are some interesting caveats that must
be considered when designing such vectors, due to presumed
interactions between AAV-encoded loxP sites on two or more
vectors. For similar reasons, there appear to be interactions
between AAV-encoded loxP sites and genomic loxP sites
(Saunders et al., 2012). Cre-dependent AAV vectors have been
exploited for transsynaptic tracing protocols and for targeting
optogenetic protein expression to specific types of neurons that
express Cre (Atasoy et al., 2008; see also ‘‘Viruses Engineered
to Carry Functional Genes’’ Section). The popularity of AAV
vectors with neuroscientists also derives from the fact that
they are straightforward to engineer, and there are multiple
companies and core facilities that make virus constructs as well
as virus preparations.
AAVs can be produced as high titer stocks [1012–1013 genome
copies per mL (gc/mL) for AAV]. Note that AAV titers are
usually given in gc/mL, and retroviral titers in infectious units
(e.g., cfu/mL). AAV stocks using different capsid types, and
different preparations of a given capsid type (Auricchio et al.,
2001), can vary in their ratio of capsids to infectious capsids, also
referred to as the particle to infectious particle ratio (p/pfu), or
infectivity. These ratios range from 10–1000:1 (Auricchio et al.,
2001; Vandenberghe, personal communication) and will affect
the percentage of cells infected at an injection site. Due to the
fact that it is not always trivial to measure infectious particle
activity for AAVs, the p/pfu ratio is usually not measured but is
one reason why stocks vary in their infectivity. The variables of
toxicity and infectivity argue for pilot experiments with each new
stock before investing a great deal of time in its use.
Although the naturally occurring AAVs integrate their
genome into the host chromosome, at a specific locus on human
chromosome 19, the deletion of the rep genes from the vector
form of AAV has led to the loss of such targeted integration
(McCarty et al., 2004). Some random integration occurs at
a low level, but it is not clear if such integrated genomes
express viral genes. Most AAV genomes exist as non-integrated
episomes, either as single viral genomes or as concatamers
(Yang et al., 1999; Nakai et al., 2000). The reason(s) that these
genomes remain stably associated with the host cell and persist
in expression has not been determined. The lack of consistent
integration makes AAV vectors a poor choice if the target cells
are dividing and retention of viral gene expression through
several cell cycles is required. As noted above, in such cases,
retroviruses are a better choice.
The natural promoters of AAV have been replaced with
promoters from other viruses, e.g., cytomegalovirus (CMV;
Boshart et al., 1985), or host cells, e.g., EF1α (Fitzsimons et al.,
2002). Other regulatory elements that can be included are
introns, to provide for splicing, polyA sites, and a regulatory
element known as the woodchuck post-transcriptional regulatory
element (WPRE), which increases the cytoplasmic level of virus-
encoded mRNAs (Donello et al., 1998; Zufferey et al., 1999). As
with all viral vectors, the exact sequences and their arrangement
in the vector can have effects on the level of expression as well
as the specificity of expression. As an example, we have found
that different intron sequences can have a major effect on the
level of expression in the retinal pigmented epithelium (Xiong
et al., Unpublished observations). Due to these variables, one
should assay for expression of an easily scored gene, such as
GFP, using a vector that has all of the regulatory elements and
the capsid serotype that one wishes to use in future experiments.
In addition, such tests should be performed on animals that
are of the age that will be used for future experiments, as we
have found that the age of the tissue at the time of inoculation
can affect the types of cells infected (Xiong and Cepko, 2014).
One can obtain a series of relatively inexpensive, small aliquots
of different serotypes from companies to test for the optimum
vector characteristics.
The major drawback of AAV vectors is their limited
packaging capacity. AAVs can only incorporate about 4.8 Kb
of DNA (Dong et al., 2010), which limits the expression
to one or two small genes, and also limits the use of
different promoter/enhancer elements. There have been several
approaches to overcome this limitation. For example, there are
trans-splicing vectors where two genomes with different exons of
a large gene are co-injected, and result is expression of a large
protein, but only if there is a high rate of co-infection (Wu et al.,
2010). However, generally if a larger genome is desired, another
vector, such as an adenovirus or lentivirus, should be considered.
Adenoviridae—Adenovirus
An adenovirus is a non-enveloped, double-stranded DNA virus,
with a larger genome and capsid than AAV, but not as large as
those of the HSVs (Knipe andHowley, 2013). Human adenovirus
type 5 (Ad5) has been developed for use for gene therapy
and most commonly used adenovirus vectors are derived from
Ad5 (Gonçalves and de Vries, 2006). The newest generation
of adenoviruses (helper-dependent adenovirus or HDV) have
had all of their genes removed, both to make the virus less
susceptible to immune systemmodulation and to create space for
transcriptional regulatory elements and large or multiple genes
(Parks et al., 1996; Ehrhardt and Kay, 2005). These HDVs have
a capacity of 35–36 Kb. Adenovirus vectors are not quite as
straightforward to genetically engineer or produce (Palmer and
Ng, 2003) relative to retroviruses and AAVs. In addition, they
remain more pro-inflammatory than retroviruses or AAV (Seiler
et al., 2007). As with AAVs, they do not integrate and thus are
not used for applications where the target cells are mitotic. Also,
as with AAVs, they can be grown to high titer, but unlike AAVs,
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they express at a high level within a few days of infection (Akli
et al., 1993). Adenovirus vectors have been directly compared to
AAVs and lentiviruses for gene transfer in the CNS, and have not
fared well in these comparisons when the time course has gone
beyond a few days (e.g., Doherty et al., 2011). Still, transient and
immediate expression of a gene, such as Cre, using adenovirus
vectors can be useful and high titer stocks that express Cre can be
purchased from several vendors.
The canine adenoviruses (CAV) are employed for their potent
retrograde transport capabilities (Kremer et al., 2000; Soudais
et al., 2001; Kissa et al., 2002; Peltékian et al., 2002; Hnasko
et al., 2006). In addition, these vectors have been used to express
Cre, and a few other genes, e.g., GFP (Kremer et al., 2000). Cre
has been used to turn on the expression of floxed endogenous
genes (Hnasko et al., 2006), including floxed genes used to
enable monosynaptic tracing by RABV (Pivetta et al., 2014).
These vectors may become increasingly useful when a DNA virus
is required, as the packaging limit of AAVs often limits the
experiments that one can do with them. As adenoviruses have
double-strandedDNA genomes, they are amenable to Cre or Flp-
mediated recombination.
Alphaviridae—Semliki Forest Virus (SFV) and Sindbis
Virus (SIN)
The alphaviruses, semliki forest virus (SFV) and sindbis virus
(SIN), are enveloped, plus-strand single-stranded RNA viruses.
They can be engineered to be replication-incompetent, and
typically grow to as high a titer as retroviruses (in the range of
108–109 cfu/mL). However, unlike retroviruses, multiple viral
genes are still expressed from these vectors, resulting in rapid
gene expression, but also rapid toxicity.
They have been used in cases where this rapid, high expression
is desirable (Bredenbeek et al., 1993; de Hoop et al., 1994; Gwag
et al., 1998; Ehrengruber et al., 1999). For example, they have
been used for robust labeling of a small number of axons of
neurons near the injection site in the brain (Ghosh et al., 2011;
Kuramoto et al., 2015), as well as for delivering genes to neurons
(including a fluorescent tag for visualization) for single-cell
electrophysiological experiments (Kopec et al., 2007; Malinow
et al., 2010), among others. However, rapid toxicity limits the
use of these vectors. The fast expression and toxicity of these
alphaviruses make them similar to VSV, though the transgene
expression from VSV is even quicker, occurring within hours
(van den Pol et al., 2009; Beier et al., 2011b, 2013b), as discussed
further below.
Viruses that Cross Synapses
Herpesviridae—HSV and PRV
HSVs are large, enveloped, double-stranded DNA viruses which
are classified into three subfamilies (Davison, 2010). PRV
and HSV-1 are members of the subfamily, alphaherpesviruses,
and are those used for circuitry tracing. Another subfamily
is the betaherpesviruses, which includes CMV, one strain of
which is the source of the popular human CMV immediate
early enhancer/promoter used extensively in expression vectors
(Boshart et al., 1985). The herpesviruses were the first to be
extensively employed to trace neuronal circuitry. Though some
of the early reports of herpesviruses traveling along nerves
were made in the 1920s (Goodpasture and Teague, 1923),
the first applications of this type of virus for tracing did not
begin until the late 1980s (Ugolini et al., 1989). In these early
studies, the virus was injected into peripheral locations, and
transmission to specific areas in the brain known to project
to the spinal cord was observed. This permitted the mapping
of brain projections onto these peripheral sites. Later studies
also examined the transmission patterns of different strains of
HSVs, such as PRV, in the brain (Card et al., 1990; Strack
and Loewy, 1990). All of these initial studies used viruses that
were replication-competent and thus could spread across many
synapses. The fact that HSV’s can spread raises a question of
safety for laboratory workers. As PRV does not infect primates
from peripheral sites of infection, this is not a major concern,
though the virus can replicate, and kill neurons, when cells of
the CNS are exposed to the virus, by direct injection (Hurst,
1933) or nasal instillation (Baskerville and Lloyd, 1977). HSV-1,
in contrast, is a natural pathogen of humans, giving rise to genital
and oral lesions (Lafferty et al., 2000). In addition, these viruses
are toxic to cells, as is true with the other viral transsynaptic
tracers.
Specific strains of the virus are able to transmit only in the
retrograde direction, as in the case of the PRV Bartha strain
(Card et al., 1992; Levine et al., 1994; Moore et al., 1995). Other
strains, such as the HSV-1 strain H129 (Zemanick et al., 1991;
Sun et al., 1996), appear to transmit transsynaptically only in the
anterograde direction. The retrograde specificity of the Bartha
strain is likely due to a large deletion in the viral genome,
which eliminates the expression of three viral genes (Lomniczi
et al., 1987), while the anterograde specificity of the HSV H129
is not understood (Szpara et al., 2010). The mechanisms of
axonal transport, both retrograde and anterograde, have been
studied, and while there is still much to be learned, the process
is better understood than for the rhabdoviruses, RABV and VSV.
However, for a good review of how difficult it is to clearly define
these mechanisms, see Kratchmarov et al. (2012).
HSVs are DNA viruses, and thus their genomes can
be engineered using standard recombinant DNA methods.
However, as these viral genomes are very large, about 150 Kb, and
have many regulatory elements and genes, even minor genome
alterations can cripple the virus’s ability to replicate. Since at least
one cycle of replication is required for a virus to transmit across
a synapse, any modification that affects viral fitness can greatly
reduce the utility of a construct. Some modifications have been
made to enable the use of these viruses as tracers. Fluorescent
protein genes have been successfully inserted, and there are
versions which include the Brainbow or rainbow cassettes of
fluorescent proteins (Boldogkoi et al., 2009; Kobiler et al., 2010).
In addition, there is a version that can be used as a calcium
sensor, and through the use of both GFP and DsRed, there is
a version which can be used to indicate the timing of arrival
of the virus in a circuit, as well as the health of infected cells
(Boldogkoi et al., 2009). PRV and H129 also have been rendered
dependent upon Cre expression for replication, allowing one to
use Cre expression patterns in transgenic mice to dictate tracing
of a particular circuit (DeFalco et al., 2001; Lo and Anderson,
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FIGURE 1 | An example of a Cre-dependent tracing strategy. The first
Cre-dependent tracing virus was a PRV that expressed a gene essential for
virus replication in neurons, thymidine kinase (TK), in a Cre-dependent manner
(DeFalco et al., 2001). A theoretical example is as follows. (1) The virus is first
injected into a region of interest with cells expressing Cre. (2) Cre recombines
the PRV genome so that it can express GFP and TK. The virus can then
transsynaptically move from the starter cells to input neurons, such as retinal
ganglion cells (RGCs) in the retina in this theoretical example. The virus can
continue to transmit polysynaptically, as once Cre recombined the viral
genome, it is permanently activated for transmission.
2011; Figure 1), or to express a variety of transgenes which can
aid in circuit mapping (Boldogkoi et al., 2009; Kobiler et al.,
2010). As mentioned above, PRV and HSV-1 are toxic to cells,
and have been suggested to have the ability to alter neuronal
connectivity (McCarthy et al., 2009). However, a variant of
PRV was recently generated that lacks the master transcriptional
regulator of endogenous PRV genes, and can therefore express
transgenes without replicating or apparent toxicity (Oyibo et al.,
2014), auguring an expanded use of these vectors. In terms of
speed, PRV has been seen to label infected tissue culture cells
in 6 h (Kobiler et al., 2010), and initially infected neurons in
vivo in just over 1 day post-infection, while the first instances
of spread in vivo were seen at around 2 days post-infection
(e.g., Card et al., 1990). As with all transsynaptic tracer viruses,
the kinetics of expression are slower in variants that reduce
the fitness of the virus. In addition, the kinetics of labeling of
circuits are determined by such variables as the distance of the
injection site to the cell bodies of the initial target cells, and the
distances from the initial sites of replication to the cell bodies
of the secondarily infected cells. Titers of these HSV vectors are
typically 107–109 cfu/ml, and the p/pfu is variable and can be up
to 40,000 (Flint, 2000) perhaps due to the fact that the virion
particle is large and complex, leading to failures in assembly
and/or uncoating.
In addition to its utility as a transsynaptic tracing vector,
HSV-1 has been engineered to be a replication-incompetent
retrograde tracer, and to be an effective vector for other types
of gene transfer into neurons (Spaete and Frenkel, 1982; Krisky
et al., 1998; Samaniego et al., 1998; Lilley et al., 2001). These
replication-incompetent vectors are not toxic to cells, and can
be made into forms that express for different lengths of time,
including several months. Given their large size, and certain
aspects of vector design, they can be engineered to express at
high levels, to express multiple genes, and to use large and/or
multiple regulatory elements. They are somewhat more difficult
to produce than some of the other vectors discussed here, but
there are core facilities that can produce them.
Rhabdoviridae—RABV and VSV
Rhabdoviruses are enveloped, single-stranded RNA viruses, with
two members, RABV and VSV, serving as transsynaptic tracers.
RABV and VSV each encode five genes, with a genome of
approximately 12 Kb. Their capsids are flexible enough to allow
packaging of genomes both significantly smaller (Epstein et al.,
1980; Timm et al., 2014), or larger (McGettigan et al., 2003), than
the native genome. The genes of RABV and VSV are expressed at
high levels, permitting robust gene expression and visualization
shortly after infection. RABV and VSV have a simple genome
organization optimized for the levels of expression of each gene,
with a gradient of expression from the 3′-most gene (highest)
to the 5′-most (lowest). RABV is typically engineered to encode
non-viral genes at the G locus, which is in the fourth position.
This means that the expression level of such a gene (Osakada
et al., 2011) is less rapid and robust than that of a gene in the first
(most 3′) position (van den Pol et al., 2009; Beier et al., 2011b,
2013b; Osakada et al., 2011). However, vectors can be made in
which the fluorophore is placed at the 3′-most end, which results
in more robust expression (Wickersham et al., 2013).
Due to fact that the genome is RNA, and rhabdoviruses do
not have a DNA phase in their lifecycle, it has been challenging to
produce infectious virus from engineered plasmids that represent
the genomes (Whelan et al., 1995; Mebatsion et al., 1996).
Nonetheless, methods have been worked out, and after a virus
preparation is made from engineered plasmids, they are then
straightforward to propagate by simply infecting host cells in
vitro (Osakada et al., 2011). It is worth noting that the lack of
a DNA phase in their replication also means that one cannot use
DNA recombinases, such as Cre, to recombine their genomes.
A summary of the unique features of RABV and VSV as
transsynaptic tracers is given below.
RABV
RABV, like HSV, can infect neurons from the axon terminals and
be retrogradely trafficked to the cell body, as well as transmit
among neurons transsynaptically in the retrograde direction
(Astic et al., 1993; Ugolini, 1995; Kelly and Strick, 2000). Its
use has been more limited than that of HSV, however, due
to the biosafety concerns of using RABV, as it is often lethal
upon human infection. However, it has been very useful for
retrograde transsynaptic tracing in non-human primates (Nassi
and Callaway, 2006; Nassi et al., 2006; Rathelot and Strick, 2006,
2009).
The first studies linking RABV to transmission from synaptic
junctions occurred in the 1970s and 1980s (Iwasaki et al., 1975;
Charlton and Casey, 1979; Tsiang et al., 1983). This was followed
by studies in which the time-course of RABV infection was
monitored in order to construct circuit diagrams. In one such
early study, the tongue muscle was injected with RABV followed
by survival times of 1–4 days in different animals (Ugolini,
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1995). As expected, after a single day, only first-order hypoglossal
motor neurons were labeled. Between 2 and 3 days post-
injection, second-order neurons in various brainstem nuclei were
identified, while 4-day survival times resulted in the labeling of
putatively third-order neurons, including forebrain nuclei. This
approach permitted the identification of a chain of connections
based on the timing of transsynaptic transmission of RABV.
Similar studies using transsynaptic transport of RABV (CVS-11
strain) have revealed connectivity in the monkey visual system
(Kelly and Strick, 2000; Nassi and Callaway, 2006; Nassi et al.,
2006).
However, the biosafety concerns inherent in using a
replication-competent RABVmade the use of this virus restricted
to a small number of labs that were proficient in its handling
and use. A major advance occurred in 2000, when RABV was
engineered to become replication-conditional by removal of the
G gene from the genome (Etessami et al., 2000). This virus could
be used in the laboratory to robustly label neurons projecting
to a defined site (Nassi and Callaway, 2007; Wickersham et al.,
2007a). In addition, because the virus could not spread, it became
more accessible to neurobiology labs who were less familiar with
viruses.
The next major advance was the use of this replication-
conditional virus for monosynaptic retrograde transmission
(Wickersham et al., 2007b). This technology permitted, for
the first time, unambiguous identification of synaptic inputs
onto defined neuronal types. It was also the first virus
whose transsynaptic specificity was physiologically verified
(Wickersham et al., 2007b). This has led to the widespread use
of these vectors to trace circuits in the rodent (discussed further
in ‘‘Engineering Viruses to Control Transport’’ Section).
As with HSVs, RABV is toxic to cells. While less rapidly
cytotoxic than other transsynaptic vectors such as VSV (van
den Pol et al., 2009; Beier et al., 2011b), and HSV-1 and
PRV (McCarthy et al., 2009), physiological analyses on RABV-
infected neurons should be performed with caution. Also, while
many studies have reported the neuronal specificity of RABV
transsynaptic tracing, others have reported that glial cells are
occasionally observed from viral infection, just as with PRV
(Viney et al., 2007; Marshel et al., 2010) and VSV (Beier et al.,
2011b). Therefore, viral transmission is not always exclusively
limited to traditional synapses.
VSV
The activity of VSV in the CNS was not studied as early as
the other transsynaptic tracers, though a few studies reported
replication in the CNS (Lundh, 1990; Plakhov et al., 1995; van
den Pol et al., 2002, 2009). The first study to modify the VSV
genome and examine its transmission patterns showed that the
virus could indeed cross synapses and label neurons (Beier et al.,
2011b). Importantly, the direction of transmission was shown to
be dictated by the nature of the glycoprotein. VSV with its own G
showed an anterograde transsynaptic transmission pattern, while
VSV encoding the RABV G showed a retrograde transsynaptic
pattern (Beier et al., 2011b).
As VSV is non-pathogenic in nature, one can safely use VSV
as a polysynaptic tracer, that is, in its replication-competent
form. Infection of a peripheral tissue leads to a rapid shut-down
of VSV replication, via the innate immune system (Junt et al.,
2007). The lack of escape from this immune response renders
VSV safe for laboratory use, which is one of the reasons why
VSV has been well studied by virologists and cell biologists.
However, direct injection of wild type VSV into the CNS can
lead to rapid spread in the brain, which can kill mice very
quickly, particularly young mice (Sabin and Olitsky, 1937). The
recombinant forms of VSV that encode fluorescent proteins and
other viral glycoproteins, such as RABV-G, are attenuated and
spread in the CNS more slowly than the wild type (Roberts
et al., 1998; Beier et al., 2011b). Other genome modifications
have been made to create a monosynaptic tracer (Beier et al.,
2011b), following the strategy used for monosynaptic RABV
(Wickersham et al., 2007b). When the glycoprotein from the
lymphocytic choriomeningitis virus (LCMV-G) was supplied
in trans in hippocampal organotypic slices, VSV was observed
to transmit between neurons in an anterograde direction. This
was confirmed electrophysiologically, by optically stimulating
the starter cell and recording from the post-synaptic neuron
(Beier et al., 2011b). VSV is currently being developed for use
in vivo, for monosynaptic and either anterograde or retrograde
transmission.
Engineering Viruses to Control Transport
Monosynaptic and Restricted Transsynaptic
Tracing Systems Offer Advantages in
Interpretation
Viruses that can cross multiple synapses have proven highly
valuable in constructing connectivity maps in various systems.
The general strategy has been to use progressively longer survival
times after injection to label progressively higher order neurons,
as discussed for RABV in the previous section (e.g., Ugolini,
1995).
While such studies have been very informative, they suffer
from two major limitations. One is that the virus infects neurons
indiscriminately at the injection site, making it impossible to
distinguish differences in inputs to different cell types that
are intermingled at one location. A second limitation is using
survival time to establish the order of connectivity. Variability in
viral replication, intracellular transport and neuronal geometry
may create timing differences in labeling that do not strictly
reflect synaptic order in a chain of connected neurons. For
example, a weak, distal input to a large pyramidal neuron may
be transsynaptically labeled considerably later than a strong,
proximal input, thus leading to confusion between distal, or
weak, nth order connections and proximal n + 1th order
connections.
The first report of a cell-type specific virus was published
in 2001 (DeFalco et al., 2001). PRV was modified to make the
expression of a gene necessary for viral replication, thymidine
kinase (TK), Cre-dependent so that tracing was only initiated
from cell types expressing Cre (Figure 1). However, as the
virus could spread across multiple synapses after activation by
Cre, it was uncertain whether the novel connections identified
represented direct monosynaptic inputs to starter neurons.
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FIGURE 2 | Design of the RABV monosynaptic technique. Expression of
the avian tumor virus receptor A (TVA) dictates the types of cells that can be
infected by a transsynaptic tracing virus that has a glycoprotein with the
extracellular domain of a type A avian retrovirus (EnvA). A chimeric protein with
the RABV-G intracellular domain fused to the EnvA extracellular domain (aka
ASLV-A/RABV-G fusion, or A/G) is often used in place of the native EnvA. (1)
The TVA and RABV-G genes are encoded as Cre-dependent genes in
adeno-associated virus (AAV) vectors (blue virions) that are injected into an
area with Cre-expressing neurons; (2) After Cre-recombination of the AAV
encoded genes, a RABV pseudotyped with EnvA (EnvA shown as purple
spikes on the virion surface) can infect the TVA-expressing cells; and (3)
transsynaptic transmission of the RABV to synaptically-connected input
neurons can occur due to the expression of the RABV-G gene (RABV-G
shown as red spikes on the virion surface) in the Cre-expressing cells. This
method enables RABV to transmit from an initially infected (“starter”) cell to a
directly connected presynaptic cell, but no further.
To address this issue, RABV was genetically modified to
allow it to specifically infect desired cell types, as well as to
spread only to monosynaptically connected inputs (Wickersham
et al., 2007b). A schematic of this process is shown in Figure 2.
Cell type specificity was obtained by expressing the viral
receptor in cell types of choice, and monosynaptic restriction
of transsynaptic spread was obtained by deleting the G gene
from the viral genome, and resupplying it in trans specifically
in cells also expressing the viral receptor. The investigators
initially delivered these genes to cortical slice cultures by biolistic
transfection, and subsequently applied the cell-type specific
RABV to these cultures. They observed that: (1) RABV infection
was specific to defined cell types; (2) the RABV G was necessary
and sufficient for transsynaptic spread; and (3) they verified
electrophysiologically that these neurons were, in 9 of 11 cases,
synaptic partners.
Use of Monosynaptic and Transsynaptic Tracing
In Vivo
Since the initial demonstration in organotypic slices, the
monosynaptic tracing technique has been applied in vivo
in numerous studies (Figure 3). In the first experiments,
investigators used mice expressing Cre in specific cell
populations and injected Cre-conditional (FLEx) viruses into
the target region (Figure 3A; Wall et al., 2010). In this case, the
Cre mice were crossed to a mouse line conditionally expressing
TVA, making only the RABV-G necessary to be delivered virally.
Other groups have delivered both TVA and RABV-G virally into
Cre populations, using either a single virus (Haubensak et al.,
2010; Wall et al., 2013) or multiple viruses (Watabe-Uchida
et al., 2012; Miyamichi et al., 2013). Another strategy used the
tet system, making the expression of tTA2 Cre-dependent, and
the AAV expressing TVA and RABV-G used the TRE promoter
(Miyamichi et al., 2011). A recent innovation will allow the use
of GFP to direct expression of Cre-dependent genes. This system
uses AAV encoding Cre-DOG (Cre-Dependent On GFP), and
AAV FLEx vectors, e.g., for TVA and RABV-G (Tang et al.,
in press; Figure 3B). This is similar to the GFP-dependent
transcription system of Tang et al. (2013). It expands the use
of transgenic GFP lines for viral tracing through, for example,
the selection of GFP+ cells as starter cells. In all of these cases,
at least one component is delivered virally (or through the use
of Cre and floxed TVA in transgenic mice) in order to spatially
restrict the neurons to be infected by RABV.
One additional method that uses TVA and RABV-G for
tracing specificity employed a strategy that is the opposite of
that outlined above. Rather than use TVA to direct the infection
of the starter cells, TVA was used to direct infection of cells
presynaptic to the starter cells (Figure 3D; Beier et al., 2013a).
A VSV vector with the EnvA fusion protein, ASLV-A/RABV-
G (A/G), in the genome was grown in vitro with the RABV-
G protein supplied in trans. This created virions with both the
A/G and RABV-G glycoproteins on the virion surface. Infection
with this preparation allowed retrograde labeling of cells that
projected to the injection site by virtue of the RABV-G on the
virion surface. Replication of the virus in the starter cells then
led to production of virions with the A/G glycoprotein on the
surface, as this was the G encoded by the viral genome. Such
virions could only infect presynaptic TVA-expressing cells. In
this way, one can interrogate the postsynaptic partners of the
TVA-expressing cells, as was done to identify retinal ganglion
cells postsynaptic to starburst amacrine cells in the retina (Beier
et al., 2013a).
While most studies have used the EnvA-TVA strategy to
direct viral infection to specific cell types, other possibilities
exist. For example, one method employed a viral receptor-
ligand bridge protein. In this strategy, TVB was conjugated to
neuregulin, which, when injected in vivo, binds to the neuregulin
receptor, Erb4 (Choi et al., 2010). This was done in order to make
cells with Erb4 on the surface also have TVB on the surface,
without requiring these cells to carry the gene expressing TVB.
RABV pseudotyped with EnvB, a viral glycoprotein that infects
cells with TVB, could then specifically infect Erb4-expressing
cells.
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FIGURE 3 | Infection of TVA-expressing cells determines specificity of
tracing. Expression of TVA can be arranged using transgenic mouse strains, by
crossing a strain expressing Cre in a neuronal cell type of interest to a strain with
a Cre-dependent TVA. In addition, one can include in this cross a
Cre-dependent G protein (e.g., RABV-G) to enable the tracing virus to transmit,
and/or a Cre-dependent fluorescent protein to label the cells with Cre history,
i.e., the TVA-expressing cells. AAV vectors encoding such Cre-dependent
genes can be used as an alternative to transgenic mouse strains (as shown in
Figure 2). Four versions of tracing experiments using TVA are shown. (A) A
transgenic mouse strain that expresses Cre, in e.g., in LGN neurons, will enable
identification of the presynaptic partners of the Cre-expression neurons. In this
example, the Cre strain is crossed to a strain with a Cre-dependent TVA gene
(Beier et al., 2011a), (or, alternatively, an AAV is delivered in step 2 with the
Cre-dependent TVA): (1) AAV encoding a Cre-dependent (FLEx) RABV-G is
injected into the LGN of mice crossed to have TVA in LGN neurons that are
postsynaptic to RGCs, approximately 2 weeks prior to the initiation of tracing.
The AAV will uncoat, make a second DNA strand, then initiate expression of the
RABV-G protein only in cells that have Cre. Depending upon the serotype of
AAV, this process can take over 1 week; (2) A second injection is then made into
the same area of the LGN with a tracer virus, RABV ∆G GFP (EnvA or A/G).
RABV ∆G GFP will only infect cells with TVA, i.e., those with Cre; (3) When
RABV ∆G GFP infects a cell that was previously infected with AAV, and which
expresses Cre, RABV ∆G GFP will be transmitted to presynaptic RGCs.
Infected RGCs will become GFP+, but will not be able to transmit the virus any
further due to the lack of the G gene in the virus and in the RGCs. (B) GFP
expression determines tracing specificity. The same strategy outlined in (A) can
be used with a transgenic mouse line that expresses GFP in the LGN: (1)
Infection of the LGN with two AAVs encoding Cre-DOG (Cre-dependent upon
GFP) enables the GFP-expressing cells to become Cre-expressing cells (Tang
et al., in press). Co-infection with an AAV with a Cre-dependent RABV-G and
TVA allows the GFP-expressing cells to express RABV-G and TVA; (2) Infection
with RABV ∆G mCherry (EnvA or A/G); and (3) transmission from the starter
cells to presynaptic cells then proceeds as in scheme shown in (A). (C) TVA
determines the starter cell type for anterograde monosynaptic tracing. The
strategy outlined in A is carried out for anterograde tracing: (1) A mouse cross or
AAV are used to determine the TVA-expressing starter cell type. The direction of
transsynaptic transmission is set by the choice of G gene, in this case, VSV-G
for anterograde tracing. If AAV is used, infection into the cortex is done 2 weeks
prior to the initiation of a tracing experiment; (2) Infection of TVA-expressing
cells by injection of VSV ∆G GFP (A/G) into the cortex; (3) VSV will replicate in
the TVA-expressing cells and if VSV-G is present, will allow transmission to
postsynaptic cells. VSV ∆G GFP will not spread from these postsynaptic cells
due to the absence of a G gene in the virus and the postsynaptic cells. (D) TVA
determines the specificity of retrograde infection from starter cells defined by
projection site: (1) TVA expression is initiated in cells as shown in (A), but the
Cre-dependent RABV-G gene is not used. Instead, one may use a
Cre-dependent tdTomato allele to enable the identification of cells with a history
of Cre expression (but this is optional). If AAV is used, infection into the LGN is
done 2 weeks prior to the initiation of a tracing experiment; (2) A VSV encoding
the A/G fusion protein in the genome, and RABV-G protein on the virion
surface, is injected, here into the LGN. The RABV-G on the virion surface allows
the VSV to travel retrogradely from the LGN injection site to neurons that project
into the LGN, e.g., layer 6 pyramidal neurons in V1; and (3) VSV will replicate in
the pyramidal neurons and transsynaptically transmit specifically to presynaptic
TVA-expressing cells in the cortex. Transmission out of these TVA-expressing
cells will only occur to other presynaptic cells that express TVA.
In addition to delivery of TVA and RABV-G by AAVs, other
studies have provided these genes by single cell electroporation in
vivo (Marshel et al., 2010; Nguyen et al., 2012). This technique has
the advantage of allowing for the physiological characterization
of the neurons that are later used for input tracing before
they are infected with RABV and potentially physiologically
compromised by the virus. It also has the advantage of allowing
the investigator to conclude that all virally labeled inputs
make direct synaptic connections onto a single, identified
cell.
The monosynaptic restriction of transsynaptic tracing does
not appear to be limited to tracing only in the retrograde
direction. Monosynaptic anterograde tracing was first achieved
in slice cultures using VSV that expressed the glycoprotein
of either LCMV or of VSV itself (Beier et al., 2011b). In
vivo applications using VSV and VSV-G are currently being
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developed (Figure 3C). A recent report also suggested that
RABV itself may display anterograde transsynaptic transmission
in certain systems (Zampieri et al., 2014). Further studies
into the mechanisms of viral transsynaptic transmission should
shed light on the mechanisms of directional viral transsynaptic
transmission, allowing for more precise direction-specific
investigation of connectivity.
Use of RABV as an Unbiased Screening Method for
Identifying Direct, Monosynaptic Inputs
One of the major advantages of the monosynaptic RABV
technique is the ability to examine direct synaptic inputs to
the targeted neuronal populations without a presupposition
about their identity or strength. The advantages of using the
monosynaptic virus for this purpose are that it does not label
axons of passage, which can be problematic when using some
classical tracers, and that its high level of amplification at the
cell body allows it to strongly label even weakly connected inputs.
For example, this approach was used to determine the inputs to
AgRP-Cre expressing neurons in the ventral hypothalamus that
are critical for the control of hunger (Krashes et al., 2014). The
major inputs were the dorsal medial hypothalamus (DMH, 26%
of inputs), and the paraventricular hypothalamus (PVH, 18%
of inputs). As the monosynaptic method suggested that these
are direct inputs, the investigators then used channelrhodopsin-
assisted circuit mapping techniques to show that the strength of
these glutamatergic afferents to the AgRP neurons was stronger
from the PVH than the DMH, and that these connections
subsequently were important for the control of feeding behavior.
Another study used the virus to suggest a potential feedforward
circuit in the PVH (Betley et al., 2013).
Monosynaptic Input Tracing used to Map Circuit
Organization
In addition to identifying the presence or absence of connections,
RABV can be used to elucidate the topology of neuronal circuits.
For example, in the olfactory circuitry in themouse, it was known
that each glomerulus in the olfactory bulb receives projections
from one type of olfactory receptor neuron, but it was unknown
how the olfactory map was represented in downstream regions,
such as in the anterior olfactory nucleus (AON), or in the
piriform cortex. RABV was injected into downstream targets of
the olfactory bulb projection neurons, the mitral and tufted cells.
It was found that the olfactory bulb-AON projection maintained
the dorsal-ventral topography present in the olfactory bulb, that
the projection to the amygdala was dorsally biased, and that the
olfactory cortex appeared to get input from a random assortment
of mitral/tufted cells. Thus RABV tracing was able to identify that
each of the three different efferent projection sites appeared to
have a different representation of the olfactory map than the one
present in the olfactory bulb, a finding supported by other studies
(Stettler and Axel, 2009; Choi et al., 2011; Sosulski et al., 2011).
These represent only a few examples of the many studies
that have used RABV to map connectivity in different circuits
throughout the central nervous system (Yonehara et al., 2011;
Sun et al., 2014) as well as the spinal cord (Stepien et al., 2010;
Tripodi et al., 2011; Esposito et al., 2014).
Use of Monosynaptic Input Tracing to Identify Input
Specificity of Different Cell Populations
The monosynaptic RABV technique has also been used to
quantitatively compare inputs to two or more different cell
populations. One study used the virus to compare the inputs
to the two major dopaminergic cell populations in the ventral
midbrain, the ventral tegmental area (VTA) and substantia nigra
pars compacta (SNc; Watabe-Uchida et al., 2012). The authors
restricted infection to dopamine neurons using a Cre mouse
line (DAT-Cre) and used injections of viruses to target the two
anatomical locations. They then counted all of the monosynaptic
inputs to each of these regions throughout the entire brain.
The first observation was that each of these regions received
direct inputs from a much wider array of brain regions than
previously appreciated. Many of these inputs were not detected
by previous studies, as they may have escaped detection using
less sensitive methods, or their relatively low abundance may
have been ascribed to an error in injection targeting. It was also
surprising that the VTA and SNc largely shared the same inputs,
in largely the same proportions, with a few unique exceptions
that include the motor cortices and subthalamic nucleus for
the SNc and the lateral hypothalamus for the VTA. A similar
approach has been used to examine the inputs to different
groups of serotonergic neurons (Ogawa et al., 2014; Pollak
Dorocic et al., 2014; Weissbourd et al., 2014), as well as the
dorsal striatum (Wall et al., 2013) and hippocampus (Sun et al.,
2014).
RABV Tracing During Development can Reveal the
Timing of Synapse Formation
Viral tracing methods have also been used to investigate the
timing of wiring and synapse formation during development.
One such study investigated neurons potentially involved
in rodent whisking behavior (Takatoh et al., 2013). The
monosynaptic technique is particularly useful for this
application, as it is able to identify when synaptic connections
between neurons are formed, which would not be possible using
classical tracers. In order to find such neurons, the investigators
used the fact that whisking is initiated postnatally, and therefore
examined inputs to the vibrissal motor neurons at different
postnatal days, with the goal of finding populations of inputs
that were specifically labeled after the onset of whisking. By
comparing the label produced by injections at P1 and P8, the
authors discovered new inputs from the rostral part of the
lateral paragigantocellularis in the hindbrain that were identified
during the later time window. As these neurons appear to get
direct input from the motor cortex, the authors suggest that the
formation of inputs from these hindbrain neurons is critical
for active whisking. Another study used RABV to examine
the formation of inputs onto newly generated neurons in the
dentate gyrus in the hippocampus, and adult-born neurons in
the olfactory bulb (Deshpande et al., 2013). In both cases, they
found that at early time points post-maturation, the majority
of the transsynaptically-labeled inputs were located nearby
the cells from which tracing was initiated. If the researchers
initiated tracing a few weeks after maturation, they observed the
presence of an increasing number of inputs located at greater
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distances from the targeted neurons, suggesting that newly born
neurons first integrate into local circuitry before they receive
inputs from distant sites. The similar pattern of observations
in both the hippocampus and the olfactory bulb may indicate
a common mechanism for integrating newborn neurons into
already-established neural networks.
Viruses Engineered to Carry Functional
Genes
In addition to the rapid development of transsynaptic viral
technologies, in the past decade there has been a veritable
explosion of genetically-encoded functional tools for measuring
and manipulating neuronal activity (Fenno et al., 2011; Looger
and Griesbeck, 2012; Farrell and Roth, 2013). These include,
but are not limited to, genetically-encoded calcium and voltage
indicators for imaging neuronal activity (Looger and Griesbeck,
2012) and optogenetic and pharmacogenetic effectors for
manipulating neuronal activity (Fenno et al., 2011; Farrell
and Roth, 2013). These new functional tools have already led
to a plethora of circuit-level discoveries, primarily aided by
transgenic strategies that target expression to specific cell-types
in localized regions of the brain (Ting and Feng, 2013). In some
cases, as in the Thy1 lines of transgenic mice, expression of these
genes can be restricted to specific subsets of projection neurons,
offering the possibility of pathway-specific functional analysis
and behavioral readout (Arenkiel et al., 2007; Dana et al., 2014).
Ultimately, though, transgenic strategies alone are insufficient
to target the many different cell-types in the brain that are
currently defined not by their genetic profile, but by their
unique pattern of connections with other neurons within
and between different brain areas (Jones, 1984; Douglas and
Martin, 2004). Recently, there has been a concerted effort
to exploit the power of viral tracers in order to deliver
these functional tools to neuronal populations defined by
their connectivity. This has led to a revolution in efforts to
directly relate structure to function, with enormous promise
for model species such as the primate for which transgenic
technology is not currently available (but see Kishi et al.,
2014).
The viral tracing tools outlined in the previous section enable
researchers to study anatomical circuits with unprecedented
precision. However, the rapid gene expression from these
vectors, which may be critical for their high efficiency of
transsynaptic transfer, makes them disadvantageous for studying
circuit function, as the speed of gene expression comes at
the expense of neuronal health. This is usually not an issue
for anatomical studies with relatively short survival times, but
it poses a major challenge for functional studies, especially
those that require chronic experimentation in behaviorally
trained animals. Therefore, in order to deliver genes to defined
neuronal classes in which long-termmonitoring or manipulation
is necessary, a different methodology and set of reagents is
required.
To be useful for functional and behavioral experiments, it
is essential that the virus of choice be able to deliver a high
payload without harming the infected cells. This has motivated
a variety of viral targeting strategies, the most successful of which
have so far involved AAV, either alone or in combination with
other viruses, due to its ability to express high levels of protein
with relatively low levels of toxicity. In most cases, regardless
of the specific functional tool or application, the relevant viral
targeting strategies are similar. Some specific examples using
these strategies have already been described in previous sections,
so here we provide a broad overview of three main types of viral
approaches that have been pursued to target the expression of
genes to specific cell types for long-term analyses, highlighting
previous and ongoing efforts to obtain a functional or behavioral
readout of a specific pathway or circuit in the brain.
Axon Terminals
The most successful integration of viruses and functional tools
thus far has relied on a viral strategy that does not explicitly
employ viruses as tracers, but, instead, simply depends on robust
expression of a virus’s genetic payload throughout the soma,
dendrites and, in particular, axons of neurons local to the
injection site (Figure 4A). AAVs and lentiviruses have been the
most commonly used viruses for purposes of local infection and
robust expression throughout the axonal tree, with the important
advantage of being chronically well-tolerated and minimally
toxic (Osten et al., 2006; Büning et al., 2008). In this way, these
viruses serve as a sort of anterograde tracer, enabling functional
analysis of specific efferent pathways originating from neurons at
the injection site (Figure 4A).
For example, in the case of optogenetics, light can be delivered
specifically to a particular target area and activate only the axon
terminals of the infected neuronal population, thus allowing the
physiological and behavioral consequences of a particular set of
inputs to be measured (Petreanu et al., 2007; Gradinaru et al.,
2009; Cruikshank et al., 2010; Stuber et al., 2011). Such axonal
stimulation can be used to map out how long-range connections
in the brain interact with a local microcircuit (Petreanu et al.,
2007) or, with the aid of functional magnetic resonance imaging
(fMRI), across the entire brain (Lee et al., 2010; Desai et al.,
2011).
For imaging applications, calcium levels within axons in
a particular target area of the infected neuronal population
can be measured (Reiff et al., 2010; Petreanu et al., 2012;
Glickfeld et al., 2013). Note that in all of these cases, pathway
specificity is not obtained by the virus alone, which will
often infect a heterogeneous population of neurons projecting
to many different brain regions. Rather, pathway specificity
is achieved by combining the viral infection of the soma
with spatial restriction of either the light beam used for
stimulation or the field of view of the microscope to a brain
region where only one particular projection pathway terminates
(Figure 4A). In some circuits, however, spatially intermixed
parallel pathways exist, requiring additional tricks to disentangle
the functional influence of one pathway from another. Cell-
type specific expression can sometimes aid in such efforts,
either by using AAVs and lentiviruses encoding cell-type specific
promoter sequences or by using transgenic lines with cell-type
specific expression of Cre-recombinase and viruses with Cre-
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FIGURE 4 | Viral strategies for delivering functional tools to
neuronal populations defined by their connectivity. (A) Axon terminal
targeting. The most successful approach to date relies on locally-infecting
viruses, such as lentivirus and adeno-associated virus (AAV), which enable
expression of a functional tool within neuronal cell bodies (dark green
triangles) and dendrites local to the injection site (area A) and throughout
their axons (green lines) that terminate both locally and in remote areas of
the brain (areas B,C,D). Specific efferent pathways originating from the
injection site are targeted by restricting stimulation or imaging (gray) to
one particular target area (area C). (B) Cell-type specific axon terminal
targeting. In some circuits, spatially-intermixed parallel pathways converge
on the same target area of interest. In order to disentangle these
pathways, the same locally-infecting viruses described in (A) can be
engineered to target specific cell-types local to the injection site (area A).
This can be accomplished with cell-type specific promoter sequences or
recombinase-dependent expression sequences that restrict expression of
a functional tool to a genetically-defined subpopulation (dark green
triangles in area A). Specific efferent pathways originating from that
particular subpopulation (green lines) and not other parallel pathways
(black lines) are targeted as in (A) by restricting stimulation or imaging
(gray) to one particular target area (area C). (C) Projection neuron
targeting. Retrograde viruses, such as rabies, enable expression of a
functional tool in specific projection neuron populations. Retrograde virus
is taken up by axonal terminations (green lines) local to the injection site
(area C) and travels back to cell bodies (dark green triangles) throughout
the brain (areas A,B,D). Specific afferent pathways projecting to the
injection site are targeted by restricting stimulation or imaging (gray) to
one particular input area (area A). Retrograde viruses alone are often
unable to achieve the high levels of expression needed for long-term
functional studies. (D) Intersectional approaches. A combination of the
strategies described in (A,C) above have enabled high levels of
expression with low levels of toxicity in specific projection-neuron
populations. The most successful strategy to date involves delivering small
amounts of Cre-recombinase via a retrograde virus and also injecting a
locally-infecting virus encoding Cre-dependent expression of a functional
tool at the location where the targeted projection neurons originate.
Specifically, retrograde virus is taken up by axonal terminations (green and
black lines) local to the injection site (area C) and travels back to cell
bodies throughout the brain (areas A,B,D). The retrograde virus expresses
Cre-recombinase within these infected projection neurons. Specific afferent
pathways (dark green triangles) projecting to the injection site are targeted
by injecting a locally-infecting virus, such as AAV, encoding Cre-dependent
expression of a functional tool in the target area of interest (area A). This
strategy can functionally isolate neurons that reside in area A and project
to area C, obviating the need for site-specific stimulation or imaging
(gray).
dependent expression sequences (Betley and Sternson, 2011;
Figure 4B).
Cell Bodies of Projection Neurons
While stimulation and imaging of axons has already led to
great progress in the field, there are many instances in which
it would be preferable to modulate or image the activity of
specific projection neuron populations at their site of origin
(Figure 4C). This is especially true when the axons of a particular
pathway are difficult to access or when they are defined not
simply by the brain area in which they terminate, but by the
specific cell-type within that area onto which they synapse.
In such cases, researchers have turned toward several of the
retrograde viruses described previously, which travel back from
axonal termination to the cell body. Similarly to the axonal
stimulation strategy described above in the ‘‘Axon Terminals’’
Section, pathway specificity is obtained not by the retrograde
virus alone, which will infect neurons projecting from many
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different brain regions, but by restricting the stimulation area
of the light or the field of view of the microscope to a brain
region where only one particular projection pathway originates
(Figure 4C).
One of the most powerful viral tracers for these purposes is
RABV, due to its exclusively retrograde spread, fast expression
dynamics and high amplification of its genes (Ugolini, 1995;
Kelly and Strick, 2000). Though not useful for chronic,
longitudinal experiments because of its relatively fast-onset
toxicity (cell death as early as 14 days post-infection), the
SAD-B19-∆G strain of rabies can be used in an acute setting
to express high levels of light-sensitive channel or calcium
indicator in specific projection neuron populations based on
the target region injected with virus (Wickersham et al., 2007a;
Osakada et al., 2011). It can also be complemented in trans
to enable monosynaptic spread restricted to the inputs of an
initially infected population of neurons (Wickersham et al.,
2007b).
For chronic experiments, however, retrograde viruses
with lower toxicity profiles are required. While potentially
somewhat cytotoxic, genetically-modified retrograde viruses
could potentially be used for these purposes, including Herpes
Simplex Virus Type 1 (HSV-1), the Bartha strain of pseudorabies
(PRV) or CAV (Kremer et al., 2000; Frampton et al., 2005;
Tomioka and Rockland, 2006; Card and Enquist, 2014). Another
possibility is to pseudotype viruses of low toxicity that do not
normally move retrogradely, such as lentivirus, with RABV or
RABV-VSV-G chimeric glycoproteins, so that they do in fact
move retrogradely from the site of injection (Mazarakis et al.,
2001; Kato et al., 2011). Ultimately, though, the expression levels
produced by most of these retrograde viruses on their own
are typically insufficient for functional efficacy. While certain
genetic modifications might enable higher expression levels
(Cetin and Callaway, 2014), it remains to be seen whether any
low-toxicity, retrograde virus on its own can produce the high
levels of expression needed for long-term chronic functional and
behavioral studies.
Intersectional Approaches
A combination of different viral approaches has recently shown
promise as a way to achieve high levels of expression with
low levels of toxicity in specific projection-neuron populations.
The most successful strategy to date involves delivering small
amounts of Cre-recombinase via a retrograde virus after injecting
a locally-infecting AAV encoding Cre-dependent expression of
a functional tool at the location where the targeted projection
neurons originate (Figure 4D). This has already been successful
with several retrograde viruses including HSV-1 (Lima et al.,
2009; Senn et al., 2014), PRV (Granstedt et al., 2010; Chaudhury
et al., 2013) and CAV-2 (Hnasko et al., 2006; Senn et al., 2014).
The approach requires careful matching of the two injection
sites in order to target the same projection population with both
viruses. Non-viral retrograde delivery of Cre-recombinase, such
as with the plant lectin WGA, is also an option (Gradinaru et al.,
2010; Xu and Südhof, 2013), though bi-directional and diluted
multi-synaptic spread of WGA may limit its utility (Köbbert
et al., 2000).
These intersectional approaches have the important added
advantage of specific expression in the particular projection
neuron population of interest, rather than all populations that
project to the injection site (Figure 4D). This, then, opens up
the possibility of using systemic rather than local effectors such
as in the case of tetracycline-controlled transcriptional activation
(tet-ON and tet-OFF) or designer receptors exclusively activated
by designer drugs (DREADDs; Mansuy and Bujard, 2000; Farrell
and Roth, 2013). Anterograde viral strategies currently under
development would likely benefit from a similar intersectional
approach and would vastly expand the pathways and circuitry
accessible to functional and behavioral analysis in future studies
(Beier et al., 2011b; Lo and Anderson, 2011). Intersectional
approaches for either anterograde or retrograde tracing also
can be employed that use the overlap of expression patterns of
Cre and Flp. These two recombinases can be expressed from
transgenic configurations (Dymecki et al., 2010) and/or via viral
delivery (Fenno et al., 2014). Use of an effector gene, such as
TVA, that is dependent upon expression of both Cre and Flp
creates greater specificity in the cell types being targeted for
infection or viral spread. This type of intersectional approach
will also benefit from a new method of manipulating GFP-
expressing cells, referred to as ‘‘Cre-dependent upon GFP’’ (Cre-
DOG) where GFP+ cells in a transgenic GFP line are induced
to express Cre (Tang et al., in press). These GFP+/Cre+ cells
can be intersectionally selected by expressing Flp from either a
transgenic locus or a virally delivered Flp.
Future Directions
The use of neurotropic viruses has vastly expanded the scope
of neuroanatomy, and the genetic engineering of these viruses
has permitted exciting new experiments in which functional
studies are coupled to anatomy in a direct way that has revealed
new insights into neural circuits. As the preceding sections have
made clear, however, there remains room for improvement along
several dimensions. In this section, we briefly consider several
major obstacles and possible strategies for overcoming them.
Reducing Toxicity
One of the major limiting factors for merging transsynaptic
viral vectors with functional approaches is their rapid toxicity.
Efforts are ongoing to reduce the toxicity of these transsynaptic
vectors, largely by mutating viral proteins. For example, a
point mutant in the VSV M protein (M51R) was used to
permit slice recordings in VSV-infected neurons where VSV
encoding the wild-type M protein was too toxic to permit
physiological investigation of post-synaptic cells (Beier et al.,
2011b). The M protein has been implicated in the persistence
of infection (Ahmed and Lyles, 1997; Desforges et al., 2001) as
well as other deleterious processes. There are several mutations
in M that can be tested for their effects on toxicity and
efficacy on transsynaptic tracing. As RABV has a similar set
of genes as VSV, similar mutations might be profitably applied
to these vectors as well. In addition, while RABV, VSV, and
PRV/HSV have been used for controlled studies of transsynaptic
transmission, synapse-restricted transmission may not be an
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exclusive property of these viruses. For example, the Borna
virus (BDV) has been reported to have patterns of neuron-
to-neuron spread consistent with transsynaptic transmission
(Carbone et al., 1987; Morales et al., 1988; Gosztonyi et al.,
1993). It may therefore be possible to engineer viruses that are
inherently less toxic than those currently used to trace synaptic
connections.
Improving Control of Transsynaptic Spread
One of the major limitations of manipulating viruses for
monosynaptic tracing is that the only two viruses thus far used
for this purpose (RABV and VSV) are RNA viruses, and are
therefore inaccessible to recombinase technology. Therefore,
no methods currently exist to modify the virus once it is
injected into the animal. However, it may be possible to directly
modify viral RNA. For example, one could take advantage of
the differential effects of three-dimensional structure on RNA
function. Riboswitches are short sequences in messenger RNAs
that bind small molecules, changing the RNA conformation and
the levels of proteins translated from those RNAs (Vitreschak
et al., 2004; Roth and Breaker, 2009). These can be screened
or selected from a pool of synthetic libraries for binding to
specific small molecules. Such RNA aptamers could be expressed
from the viral genome, and could bind to a small molecule
administered to the animal after the virus was injected. It may
also be possible to express shRNAs or antisense transcripts
within certain cell types that could either eliminate or slow
viral replication and/or transcription within those cells. Also, we
may be able to take advantage of the clues that Mother Nature
has provided. The innate immune response, which limits the
spread of VSV, but not RABV, from the periphery may provide
a mechanism to limit spread once a virus enters the CNS. We
will need to better understand the immune response to different
transsynaptic viruses to exploit this system.
Improving the Efficiency of Transsynaptic Spread
We currently have only a limited understanding of how
transsynaptic spread occurs. It is not always appreciated that
these viruses spread among non-neuronal cells in vitro. That is,
synapses are not needed for infection or for transmission, and
many different cell types can host virus replication. Studies of
the mechanism(s) that limit spread to synaptically connected
neurons in vivo, as well as govern the direction of spread, are
needed to allow an improvement in efficiency, which is currently
only 2–5% for retrograde labeling of presynaptic partners of VSV
and RABV (Marshel et al., 2010; Beier et al., 2013a). In addition,
the mechanisms that limit transmission in some species, such as
Drosophila, require investigation.
Extending the Range of Species that can be
Studied
The vast majority of anatomical studies cited in this review
were performed in mice. Mouse genetics have allowed for
a great deal of flexibility in the design and execution of
experiments that rely on the introduction of genes that direct
infection and spread of the virus. However, it is clearly necessary
to extend viral tracing methods to other organisms—ranging
from flies to monkeys—both because such animals represent
important model systems in their own right and because
comparative studies are essential to investigate the evolution
of circuits. One virus with the potential to infect a wide
range of species is VSV, which was recently shown to infect
neurons in animals ranging from invertebrates to nonhuman
primates and to replicate and be transported in several important
model organisms, including zebrafish and chicks (Mundell et al.,
2015).
The current use of transsynaptic viral vectors is limited to
the capabilities of the vectors used. That is, we currently have
only a limited understanding of how viruses transmit among
neurons in the CNS. While RABV, VSV, and HSV/PRV have
all displayed the potential to transsynaptically label neurons
in multiple species, this could be expanded by, for example,
expressing the appropriate viral receptors in the host cells,
and/or enabling replication in otherwise non-permissive cells.
For example, VSV does not appear to replicate in Drosophila
neurons as a result of an innate immune response that triggers
autophagy (Shelly et al., 2009). Developing a more nuanced
understanding of the mechanisms of viral infection, replication,
and transmission at the basic science level will permit a
whole new generation of transsynaptic techniques that have
the potential to refine and enhance the capabilities of these
methods.
Closing Remarks
The considerations presented above remind us of the power,
beauty and critical importance of research on the basic
mechanisms of biology—even, or especially, of such seemingly
exotic creatures as viruses. While some might believe that the
main reason to study viruses is to create vaccines that limit
their spread in human populations, it should be clear that we
need to understand these remarkable entities in much more
mechanistic detail so that we can engineer the next generation
of neuroanatomical tools with which to solve the function of
circuits within our brains and thus to tackle other devastating
diseases—diseases of brain mis-wiring, such as autism (Minshew
and Williams, 2007; Gepner and Féron, 2009) and schizophrenia
(Rubinov and Bassett, 2011).
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